Uppsala, Sweden

Eggert Brekkan

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eggert Brekkan: Innovator in Chelator Technology

Introduction

Eggert Brekkan is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of chelators for biomolecule detection and purification. With a total of three patents to his name, Brekkan's work has advanced the understanding and application of metal ion binding in biological systems.

Latest Patents

One of Brekkan's latest patents is titled "Chelator and use thereof." This invention focuses on dimeric pentadentate chelators that exhibit exceptionally strong binding to metal ions. These chelators are designed for the detection, immobilization, and purification of biomolecules. The innovative aspect of dimeric chelators lies in their ability to bind two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule. This dual binding mechanism enhances the strength of binding compared to traditional monomer chelators. Additionally, the use of dimeric chelators increases selectivity, making it easier to separate tagged biomolecules from non-tagged ones that have low metal-ion affinity.

Career Highlights

Eggert Brekkan has worked with prominent companies in the bioprocessing sector, including GE Healthcare Bioprocess R&D AB and Cytiva Bioprocess R&D AB. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in bioprocessing technologies.

Collaborations

Throughout his career, Brekkan has collaborated with several professionals in the field. Notable coworkers include Mattias Algotsson and Lars C Andersson, who have contributed to various projects alongside him.

Conclusion

Eggert Brekkan's work in the development of dimeric pentadentate chelators represents a significant advancement in the field of biochemistry. His innovative approach to metal ion binding has the potential to enhance biomolecule purification processes, making a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…